Stock Doctor

About the Author Stock Doctor

I am an individual investor who has been actively involved in the healthcare and biotechnology space for over 15 years. I hold a PhD in the biomedical sciences and have worked in both large pharmaceutical and small biotech companies. I make investments based on the fundamentals of a company and if I believe they have a superior technology or products compared to the competition. I'm an investor who believes patience pays off.

Why Caladrius Biosciences (CLBS) Stock Is Significantly Undervalued

Those that follow my articles know that I tend to focus mainly on undervalued microcap or smallcap biotech companies. A lot of my …

Ignyta Inc (RXDX) Could Make You Big Time Money

I have written a lot of articles over the years concerning my biotech investments and thankfully have done pretty well anticipating good entry …

MEI Pharma Inc (MEIP) Poised To Move Higher; Here’s Why

When investing in biotech companies, I try to find undervalued companies with low-risk upcoming catalysts. For example, several months ago when Medivation (NASDAQ:MDVN) …

MEI Pharma Inc (MEIP): ASH Abstract Data Supports Advancement Of Pracinostat In MDS And AML

I wrote an article last week detailing why investors should buy MEI Pharma Inc (NASDAQ:MEIP) before the American Society of Hematology (ASH) meeting on Decemeber …

Acorda Therapeutics Inc (ACOR): Short Squeeze Set To Begin As Ampyra Patent Challenges Resolve

It would be an understatement to say the last few weeks have been harsh for biotech investors. However, I have used the dip …

Medivation Inc (MDVN) Destined To Become A Biotech Behemoth As Low-Risk Pipeline Expands

After hitting a high of $140 per share in March, Medivation Inc (NASDAQ:MDVN) has been on a downward trend despite nothing but good …

OncoSec Medical Inc (ONCS): Upcoming Catalysts And Big Pharma Interest Has It Poised To Run

Those that follow my biotech recommendations know that I look for undervalued small cap stocks with significant upside. Some may be momentum plays, …

Cytokinetics, Inc. (CYTK) Is Proof That Biotech Bargains Still Exist

In today’s market with most biotech companies sporting bloated valuations it can be hard for investors to find stocks with significant upside. I …

Medivation Inc’s Fall Based On Incomplete, Misinterpreted ASCO Scoring System (MDVN)

Medivation Inc (NASDAQ:MDVN) has been in a free fall ever since the ASCO conference at the beginning of June, losing over 20% of its …

OncoSec Medical Inc: Flying Under The Radar With Promising Potential

My investment strategy is simple. Find small-cap undervalued biotech companies with promising drugs and significant short and long term upside.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts